[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335471-105":59,"doc-detail-335471-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","challenges-and-strategies-toward-oncolytic-virotherapy-for-leptomeningeal-metastasis","Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis","","Leptomeningeal metastasis (LM) commonly arises in advanced cancer and is associated with rapidly declining survival and quality of life, yet standardized treatments remain limited. Oncolytic viruses (OVs) represent an emerging therapeutic class that selectively replicates in cancer cells, delivers eukaryotic transgenes, triggers immunogenic cell death, and enhances anti-tumor immunity. This review evaluates prior virotherapy research for LM, summarizes reported efficacy and safety, and analyzes the feasibility of applying OVs delivered via cerebrospinal fluid (CSF) injection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/challenges-and-strategies-toward-oncolytic-virotherapy-for-leptomeningeal-metastasis/335471/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/challenges-and-strategies-toward-oncolytic-virotherapy-for-leptomeningeal-metastasis/335471.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is leptomeningeal metastasis considered a serious complication in advanced cancer?","Question",{"text":112,"@type":113},"LM involves malignant tumor spread to the meninges and often leads to a rapid decline in survival and quality of life. Without effective treatment, median survival is limited.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What advantages make oncolytic viruses a promising therapy for LM?",{"text":117,"@type":113},"Oncolytic viruses can selectively replicate in cancer cells, deliver therapeutic transgenes, induce immunogenic cell death, and promote anti-tumor immunity. These properties support their potential clinical value for LM.",{"name":119,"@type":110,"acceptedAnswer":120},"What delivery approach is discussed for applying oncolytic viruses to leptomeningeal metastasis?",{"text":121,"@type":113},"The review analyzes the feasibility of injecting oncolytic viruses into the cerebrospinal fluid (CSF). This delivery strategy is relevant to targeting leptomeningeal disease.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335471,1790183496,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Zhao et al. Journal of Translational Medicine (2024) 22:1000  \n[https://doi.org/10.1186/s12967-024-05794-4](https://doi.org/10.1186/s12967-024-05794-4)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nChallenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis  \nJia‑Li Zhao 1†, Bi‑Lin Lin 1†, Chen Luo1, Yan‑ling Yi 1, Peng Huang1, Yu Chen1, Sha Zhao1, Zhen‑Jie Huang 1, Xin‑Yi Ma 1 and Long Huang1*  \nAbstract  \nMeningeal metastasis (LM) is commonly seen in the advanced stages of cancer patients, often leading to a rapid decline in survival time and quality of life. Currently, there is still a lack of standardized treatments. Oncolytic viruses (OVs) are a class of emerging cancer therapeutics with the advantages of selectively replicating in cancer cells, delivering various eukaryotic transgenes, inducing immunogenic cell death, and promoting anti‑tumor immunity. Some studies applying OVs intrathoracically or intraperitoneally for the treatment of malignant pleural and peritoneal effusions have shown promising therapeutic effects. If OVs could be applied to treat LM, it would bring significant survival benefits to patients with LM. In this review, we analyzed past research on the use of viruses to treat menin‑ geal metastasis, summarized the efficacy and safety demonstrated by the research results, and analyzed the feasibil‑ ity of oncolytic virus therapy for meningeal metastasis. We also summarized the existing data to provide guidance for the development of OVs that can be injected into the cerebrospinal fluid (CSF) .  \nKeywords Leptomeningeal metastasis, Oncolytic virotherapy, Intra‑CSF, Oncolytic virus  \nIntroduction  \nLeptomeningeal metastasis (LM) refers to the involvement of the meninges by malignant tumors through hematogenous spread, seeding via cerebrospinal fluid (CSF), or direct invasion by adjacent tumors, and it is a serious complication often seen in the advanced stages of cancer patients [1]. Radiologically, it manifests as enhancement of the pia mater on central nervous system (CNS) Computed Tomography/Magnetic Resonance Imaging (CT/MRI) scans [2]. Patients often suffer from increased intracranial pressure and compression of brain tissue by CSF accumulation, leading to symptoms such as headache, vomiting, intellectual disabilities, and gait  \n†Jia‑Li Zhao and Bi‑Lin Lin contributed equally to this work.  \n*Correspondence:  \nLong Huang [huanglongdoctor@163.com](huanglongdoctor@163.com)  \n1 Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1 Minde Road, Nanchang, Jiangxi, China  \ndisturbances. When the brain parenchyma and meninges are involved, symptoms such as seizures, meningeal irritation signs, and motor disabilities may occur. Additionally, it can affect intracranial nerves causing impaired nerve function such as facial numbness, speech difficulties, etc.; involving the cauda equina can lead to caudaequina syndrome such as incontinence of urine and feces [3]. Virtually all malignant tumors can develop leptomeningeal metastases. Notably, the highest incidence of LM is observed in breast cancer (12–35%), lung cancer (10–26%), and melanoma (5–25%) [4, 5]. The incidence and prevalence of LM may increase due to a combination of factors, including improvements in imaging technology, lower thresholds for initiating diagnostic tests, and improvements in systemic control and prolonged survival of patients with malignant tumors [3].  \nWithout treatment, patients with LM have a life expectancy of approximately 6–8 weeks. For those who undergo active treatment, the median survival ranges from 3 to 11 months [6]. Current treatment modalities  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to t","cbCaigvnahkUKC3G","https://ap.wps.com/l/cbCaigvnahkUKC3G","pdf",1217086,18,"English","# Introduction\n## Leptomeningeal metastasis overview\n## Current treatment limitations\n# Oncolytic virotherapy rationale\n## Mechanisms of oncolytic viruses\n## Delivery considerations for LM\n# Review scope and analysis approach\n## Efficacy and safety summary\n## Feasibility of CSF-injected OVs\n# Conclusions and development guidance","[{\"question\":\"Why is leptomeningeal metastasis considered a serious complication in advanced cancer?\",\"answer\":\"LM involves malignant tumor spread to the meninges and often leads to a rapid decline in survival and quality of life. Without effective treatment, median survival is limited.\"},{\"question\":\"What advantages make oncolytic viruses a promising therapy for LM?\",\"answer\":\"Oncolytic viruses can selectively replicate in cancer cells, deliver therapeutic transgenes, induce immunogenic cell death, and promote anti-tumor immunity. These properties support their potential clinical value for LM.\"},{\"question\":\"What delivery approach is discussed for applying oncolytic viruses to leptomeningeal metastasis?\",\"answer\":\"The review analyzes the feasibility of injecting oncolytic viruses into the cerebrospinal fluid (CSF). This delivery strategy is relevant to targeting leptomeningeal disease.\"}]","Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis | PDF",1790011085,45]